3557 results for «259»
3557 results
Sirolimus coated balloon: expanding the scope of coronary artery disease treatment
07 Oct 2022 – From AICT-ASIAPCR 2022
Consult this session to understand the technology and scientific evidence of the novel sirolimus drug-coated balloon, to learn its utility for PCI in a variety of lesion and patient subsets and to understand the evidence and outcomes in real-world patients.
Treatment of small vessel disease - To stent or not to stent?
07 Oct 2022 – From AICT-AsiaPCR 2022
Consult this session if you want to learn the tips and tricks to perform a small vessel disease intervention and to discuss the pros and cons of treating small vessel disease with DCB and/or DES.
Evolving approaches to planning and guiding of complex PCI with ultra-low contrast
06 Oct 2022 – From AICT-ASIAPCR 2022
In this session, presenters describe how to use IVUS and physiology in the assessment of left anterior descending and/or left circumflex ostium in distal left main disease. Discover in the second part the general principles and clinically validated strategies for ultralow contrast coronary angiography and zero...
Beginning with the end in mind - FFR vs. IVUS imaging
06 Oct 2022 – From AICT-ASIAPCR 2022
Consult this session if you want to explore different plaque modification techniques and technology and see how to maximise PCI outcome with IVUS imaging. Also assess when to select FFR to determine when to treat vs. IVUS to determine where and how to treat.
AICT-AsiaPCR 2022 Opening Ceremony
06 Oct 2022 – From AICT-AsiaPCR 2022
After two years without being able to meet, the joy of opening this 2022 session of the AICT-AsiaPCR Congress is palpable in this video broadcasting the opening ceremony. After a quick retrospective of the previous editions, the presenters unveil the objectives of this 2022 version and...
Beyond the guidelines of STEMI management: challenges in Southeast Asia
06 Oct 2022 – From AICT-AsiaPCR 2022
In this session, observe several challenging STEMI cases, such as a 48-year-old non-smoking Thai man with gout admitted for chest pain, or a 68-year-old woman with a history of HT, DM2, and PAD who presented with an anterior lateral STEMI and was indicated for PPCI, and...
PCI calcified lesion - Session with LIVE case
06 Oct 2022 – From AICT-AsiaPCR 2022
Watch this LIVE case preceded by a discussion regarding the PCI of a calcified lesion on a 75-year-old male with hypertension and hyperlipidemia who presented with Class III angina. Non-invasive evaluation showed significant LAD and RCA disease, normal LVEF and no significant valvular disease...
Ultra-low contrast PCI - Session with LIVE case
06 Oct 2022 – From AICT-AsiaPCR 2022
Watch this LIVE case followed by a discussion regarding a 75-year-old female with hypertension, hyperlipidemia, diabetes and stage 3 CKD, presenting with class III angina. The lab investigations revealed a diffuse triple vessel disease...
Strategies for successful medical writing
06 Oct 2022 – From AICT-AsiaPCR 2022
What a pleasure to be able to read and re-read one of your own articles once it has been published! Follow this session to get tips and tricks on how to get published and produce quality writing, and to learn how to use all media, including...
Lifetime management of patients with aortic stenosis
06 Oct 2022 – From AICT-AsiaPCR 2022
In this AICT-AsiaPCR 2022 session, review a ViV case to consider coronary occlusion and CT analysis, and examine a TAVI case to discuss failed TAVI bioprosthesis, so as to develop strategies for patients with AS and long-life expectancy.
Duration of DAPT in high bleeding risk and FFR guided PCI vs. CABG for TVD: a guide to interpreting non-inferiority trials
07 Oct 2022 – From AICT-AsiaPCR 2022
Take advantage of this AICT-AsiaPCR 2022 session to learn in detail about the FAME 3 and MASTER-DAPT trials and how to use their results in daily practice, and to better understand what is behind the term "non-inferiority" and when and how to choose a non-inferiority margin.
Rotational atherectomy for the treatment of calcified coronary lesion - Session with LIVE case
07 Oct 2022 – From AICT-AsiaPCR 2022
Let's see how this 80-year-old female patient with hypertension, hyperlipidaemia, diabetes mellitus, chronic kidney disease, history of ischaemic heart disease (2018) and NSTEMI (August 2022), currently asymptomatic but mainly homebound, was treated LIVE, and learn more about the treatment of calcified coronary lesion.
DCB in variable day-to-day clinical scenarios
07 Oct 2022 – From AICT-AsiaPCR 2022
In this AICT AsiaPCR 2022 session 4 cases will be discussed that will enable you to learn more about drug-coated balloons and the variable indications for their use in daily practice, or techniques for using them in different lesion settings.
Treatment of calcified lesions
07 Oct 2022 – From AICT-AsiaPCR 2022
Consider a 66-year-old man, hypertensive and diabetic for 10 years, with history of recurrent substernal chest pain and exertional dyspnea, who presented with easy fatigability and shortness of breath, or a 72-year-old man on dialysis who presented with STEMI and severe calcified stenosis of LAD/DI bifurcation,...
First-in-human evaluation of a novel sirolimus-eluting ultra-high molecular weight APTITUDE bioresorbable scaffold: 9- and 24-month imaging and clinical results of the RENASCENT II trial
18 Jun 2020
The novel sirolimus-eluting ultra-high molecular weight APTITUDE bioreabsorbable vascular scaffold (BRS) displays higher mechanical strength, expansion capabilities and resistance to fracture compared to other BRS technologies. RENASCENT II is a prospective, multicentre first-in-human clinical study evaluating the clinical performance of the APTITUDE BRS in the treatment...
Authors :
Management of mitral regurgitation patients undergoing TMVI screening
13 Jan 2022
This study's results emphasise the strengths and limitations of transcatheter mitral valve implantation (TMVI) as a novel and promising therapy providing predictable elimination of MR in most patients, by S. Ludwig et al.
SURTAVI: five-year results from a randomized trial of TAVR vs. SAVR in patients at intermediate surgical risk
07 Nov 2021
Although TAVI is an accepted alternative to surgery in patients with severe aortic stenosis who are at high surgical risk, less is known about long-term comparative outcomes among patients with aortic stenosis who are at intermediate surgical risk. P. Redaelli & M. Pighi review the SURTAVI trial...
Author
Author
